Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs HALO✓SelectedUSD · HALOGSK vs HALO performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs HALO

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+64.4%
HALO return
+146.0%
Excess return
-81.6%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioHALOExcessAlpha
1D-0.1%-3.8%+3.7%+0.5%
7D-1.3%-6.2%+4.9%-0.3%
30D+2.7%-20.8%+23.5%+6.2%
3M+2.7%-2.2%+4.9%+2.7%
6M+3.3%+43.8%-40.4%-2.9%
YTD+6.5%+43.4%-36.9%0.0%
1Y+10.7%+37.8%-27.1%+4.4%
3Y+64.4%+144.2%-79.8%+48.1%
All+64.4%+146.0%-81.6%+48.1%

Cumulative growth

Daily Returns

Daily percentage return beside HALO.

Daily Out/Under-Performance

Portfolio return minus HALO return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × HALO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded HALO wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling